Loading clinical trials...
Loading clinical trials...
A First-in-Human, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of an Implantable Device for Direct Bladder Wall Stimulation in Participants With Lower Urinary Tract Symptoms of Underactive Bladder
Conditions
Interventions
Direct Bladder Wall Stimulation
Locations
2
Australia
Sydney Adventist Hospital
Wahroonga, New South Wales, Australia
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Start Date
September 24, 2025
Primary Completion Date
September 1, 2028
Completion Date
September 1, 2028
Last Updated
February 9, 2026
Lead Sponsor
Iota Biosciences, Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions